Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pegylated granulocyte colony-stimulating factor

Known as: mecapegfilgrastim 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
  • F. Xu, Z. Jiang
  • Annals of translational medicine
  • 2020
  • Corpus ID: 212731442
We thank Dr. Tirelli, Dr. Carbone, Dr. Francia and Dr. Di Francia for the interest they have taken in our paper “Efficacy and… Expand
2020
2020
Chemotherapy is still one of the main tools for treatment of pediatric and adult blood and solid tumors and is capable of cure… Expand
2019
2019
Background This study aimed to evaluate the efficacy and safety of mecapegfilgrastim (HHPG-19K) with different doses compared to… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2019
2019
Background Neutropenia is a common complication from chemotherapy. Mecapegfilgramtim (code name HHPG-19K), a long-acting… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
2019
Review
2019
Mecapegfilgrastim (HHPG-19K) is a long-acting pegylated recombinant human granulocyte-colony stimulating factor (rhG-CSF) that is… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Review
2019
Review
2019
  • Yong Wang, Lin Chen, +4 authors Y. Li
  • Scientific Reports
  • 2019
  • Corpus ID: 204887547
The optimum granulocyte colony-stimulating factor (G-CSF) treatment for cancer patients after being treated with cytotoxic… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2016
2016
BACKGROUND Mecapegfilgrastim (code name HHPG-19K) is a biosimilar to pegylated recombinant human granulocyte-colony stimulating… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3